Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

54,571 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Insulin sensitivity during combined androgen blockade for prostate cancer.
Smith MR, Lee H, Nathan DM. Smith MR, et al. Among authors: lee h. J Clin Endocrinol Metab. 2006 Apr;91(4):1305-8. doi: 10.1210/jc.2005-2507. Epub 2006 Jan 24. J Clin Endocrinol Metab. 2006. PMID: 16434464
Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism.
Pitteloud N, Hayes FJ, Dwyer A, Boepple PA, Lee H, Crowley WF Jr. Pitteloud N, et al. Among authors: lee h. J Clin Endocrinol Metab. 2002 Sep;87(9):4128-36. doi: 10.1210/jc.2002-020518. J Clin Endocrinol Metab. 2002. PMID: 12213860 Clinical Trial.
Effects of oral androstenedione administration on serum testosterone and estradiol levels in postmenopausal women.
Leder BZ, Leblanc KM, Longcope C, Lee H, Catlin DH, Finkelstein JS. Leder BZ, et al. Among authors: lee h. J Clin Endocrinol Metab. 2002 Dec;87(12):5449-54. doi: 10.1210/jc.2002-021035. J Clin Endocrinol Metab. 2002. PMID: 12466335 Clinical Trial.
After androstenedione administration, we made hourly measurements of serum androstenedione, estrone, estradiol, and testosterone concentrations during 12 h of frequent blood sampling. ...
After androstenedione administration, we made hourly measurements of serum androstenedione, estrone, estradiol, and testosterone concentrati …
The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.
Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM. Finkelstein JS, et al. Among authors: lee h. N Engl J Med. 2003 Sep 25;349(13):1216-26. doi: 10.1056/NEJMoa035725. Epub 2003 Sep 20. N Engl J Med. 2003. PMID: 14500805 Clinical Trial.
Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods.
Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D, Neubauer G, Klibanski A. Miller KK, et al. Among authors: lee h. J Clin Endocrinol Metab. 2004 Feb;89(2):525-33. doi: 10.1210/jc.2003-030680. J Clin Endocrinol Metab. 2004. PMID: 14764757
Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition.
Smith MR, Goode M, Zietman AL, McGovern FJ, Lee H, Finkelstein JS. Smith MR, et al. Among authors: lee h. J Clin Oncol. 2004 Jul 1;22(13):2546-53. doi: 10.1200/JCO.2004.01.174. J Clin Oncol. 2004. PMID: 15226323 Clinical Trial.
Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial.
Smith MR, Fallon MA, Lee H, Finkelstein JS. Smith MR, et al. Among authors: lee h. J Clin Endocrinol Metab. 2004 Aug;89(8):3841-6. doi: 10.1210/jc.2003-032058. J Clin Endocrinol Metab. 2004. PMID: 15292315 Clinical Trial.
Effects of low-dose prednisone on bone metabolism.
Ton FN, Gunawardene SC, Lee H, Neer RM. Ton FN, et al. Among authors: lee h. J Bone Miner Res. 2005 Mar;20(3):464-70. doi: 10.1359/JBMR.041125. Epub 2004 Nov 29. J Bone Miner Res. 2005. PMID: 15746991 Clinical Trial.
Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men.
Pitteloud N, Mootha VK, Dwyer AA, Hardin M, Lee H, Eriksson KF, Tripathy D, Yialamas M, Groop L, Elahi D, Hayes FJ. Pitteloud N, et al. Among authors: lee h. Diabetes Care. 2005 Jul;28(7):1636-42. doi: 10.2337/diacare.28.7.1636. Diabetes Care. 2005. PMID: 15983313
Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma.
Lee H, McGovern K, Finkelstein JS, Smith MR. Lee H, et al. Cancer. 2005 Oct 15;104(8):1633-7. doi: 10.1002/cncr.21381. Cancer. 2005. PMID: 16116596 Clinical Trial.
54,571 results
Jump to page
Feedback